COS.L Regulatory News (COS)

Collagen Solutions Plc

(the "Company" or the "Group")

London Investor Symposium

Monday 26 February 2018

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen and tissue components for use in regenerative medicine applications including orthopaedics, dental, wounds and cardiovascular, is delighted to confirm that it will hosting an afternoon presentation for investors on Monday, 26 February 2018. Jamal Rushdy, CEO of the Company, will give an update on recent news and key milestones expected this year on ChondroMimetric®, the Company's proprietary product, a minimally-invasive surgically placed scaffold for the repair of knee cartilage defects. Jamal will also provide a summary of the Company's core business activities over the next period. This will also be an opportunity for investors to be introduced to Hilary Spence, who has recently been appointed as CFO.

The event will take place in the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 5.30pm for a 5.45pm start. This will be followed by drinks and canapes, and a chance to network.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

Enquiries: